ライフサイエンスコーパス: device

1 tandard endoscopic equipment and a novel AWC device.

2 of 6-24 months using a remote pupillography device.

3 atabase directly from the carotid ultrasound device.

4 to be patterned or integrated with a larger device.

5 , which have yet to be addressed in a single device.

6 transplantation, and left ventricular assist device.

7 robustness of QDCs as a practical electronic device.

8 , prosthetic valve, previous IE, and cardiac device.

9 ally conducted in automated sample-to-answer devices.

10 he development of integrated soft electronic devices.

11 fisheries not equipped with turtle excluder devices.

12 perties of BAs for application in electronic devices.

13 ention for realizing carbon-based electronic devices.

14 ntable parts as an alternative to commercial devices.

15 this opens avenues for magnetooptical memory devices.

16 e potential was registered by the fabricated devices.

17 d materials, and the development of acoustic devices.

18 increasingly complex and powerful electronic devices.

19 esign and implementation into optoelectronic devices.

20 s adaptable to inexpensive, real-time sensor devices.

21 clinical chemistries, and data from wearable devices.

22 ally large-scale manufacturing of functional devices.

23 tial for the realization of advanced quantum devices.

24 ay find wide applications for optoelectronic devices.

25 ies or parallel (and in any order) on simple devices.

26 es, to water purification and optoelectronic devices.

27 n comparison to commonly used depletion mode devices.

28 and combined paclitaxel versus nonpaclitaxel devices.

29 ng alternative to ILs for advanced thin-film devices.

30 ial for their applications in optoelectronic devices.

31 rapid prototyping of various types of haptic devices.

32 tal role in several industrial processes and devices.

33 al platform for near-infrared optoelectronic devices.

34 ral and optical quality of III-nitride-based devices.

35 erits toward the fabrication of microfluidic devices.

36 ures for all the biometric variables between devices.

37 single-crystal and bicrystal gold microscale devices.

38 for their integration in future spintronics devices.

39 ike motion and tasks in untethered, man-made devices.

40 of increasing the efficiency of photovoltaic devices.

41 mises a scalable pathway to high-performance devices.

42 obotics, morphing structures, and biomedical devices.

43 and mobilities toward novel (opto)electronic devices.

44 ll as fully monolithically integrated e-skin devices.

45 dence generation is even sparser for medical devices.

46 ties for potential applications in ultrafast devices(1-3).

47 ant; paclitaxel (12.8%) versus nonpaclitaxel devices (15.5%; adjusted HR=0.85 [95% CI, 0.72-1.00], P=

48 h a waterproofed thigh-mounted accelerometer device (activPAL3 micro; PAL Technologies Ltd., Glasgow,

49 This device allows for continual and long-term measurements o

50 The monolithic device allows simultaneous measurements of the orthogona

51 The novel device allows the user to ionize an extended range of ch

52 The exceptional quality of our devices allows us to show that Brown-Zak minibands are 4

53 tetrahydrocannabinol products in e-cigarette devices, although a wide variety of products and devices

54 sure to radiofrequency energy and changes in device and lead parameters immediately after MRI.

55 tronger with increasing relative load of the device and with geolocators attached using elastic harne

56 on of integrated exciton optoelectronic nano-devices and applications in light generation, computing,

57 es to generate comparative data on drugs and devices and assure timely availability of evidence that

58 ational and parameters employed to study MET devices and electroactive microorganisms.

59 er, changes in the use of mechanical lifting devices and experiences of musculoskeletal symptoms and

60 complex and molecularly thin superlattices, devices and integrated circuits.

61 extensively studied, with various photonics devices and optical links being demonstrated.

62 efficacy and safety with contemporary S-ICD devices and programming despite the relatively high inci

63 ty to design high-performance ion-regulating devices and promotes the utilization of sustainable wood

64 rial assemblies for next generation wearable devices and robotics.

65 ality/energy-efficiency of future electronic devices and smart systems.

66 use in applications involving light-emitting devices and solar cell technology.

67 , and safe delivery of diagnostic biosensing devices and therapeutic agents to the target tissues, or

68 h surfaces is crucial for vertically stacked devices and, hence, the design of functional interfaces.

69 uding the use of a paracorporeal lung assist device, and differences in surgical technique, including

70 ere obtained on a prototype swept-source OCT device, and the VISTA algorithm was applied to visualize

71 nsidered for quantum computing, neuromorphic devices, and CMOS transistors.

72 rated circuits are present in all electronic devices, and enable signal amplification, modulation, an

73 into flow-injection analyzers, microfluidic devices, and lab-on-a-chip systems.

74 tromechanical and stretchable optoelectronic devices, and pave a way to control the local electric fi

75 (ICC < 0.8) across binarization thresholds, devices, and plexuses.

76 at a lower current density than the smaller devices, and the IQE had a larger droop as the current d

77 romote the development of novel straintronic device applications.

78 r exploring intriguing physics and potential device applications.

79 ntum yield draw attention for optoelectronic device applications.

80 imple subtractive process for creating novel device architectures and improving the structural and op

81 as information elements in future spintronic device architectures.

82 These devices are affordable but generally rely on a single mo

83 When the devices are in the QAH state with well-aligned magnetiza

84 Organ-on-chip (OOC) devices are miniaturized devices replacing animal models

85 enges with fabrication and implementation in devices are overcome, adaptive molecular crystals can ha

86 novel nanomaterial structures and associated devices are presented.

87 Devices are readily fabricated from single vapor-phase g

88 nts in an outreach setting; however, not all devices are suitable in terms of image quality and diagn

89 nd a binary memcapacitor, scalable down to a device area of 60 nm(2).

90 ients with a CIED and in 10 patients with no device as a control group.

91 receptor system with a passive piezoelectric device as the tactile sensor.

92 n of CBP against a pulse wave analysis (PWA) device (Atcor Medical Sphygmocor XCEL) (n = 5) revealed

93 Current clinical devices based on biochemical extraction and microfluidic

94 This study may enable the realization of devices based on carbon nanomaterials with exotic quantu

95 demonstrated using four bulk-heterojunction devices based on narrow-gap donor polymers.

96 his work paves a path towards the skyrmionic devices based on van der Waals layered heterostructures.

97 rvation is the most extensively investigated device-based therapy for hypertension, and randomized, s

98 t mouse cholangiocytes in the channel of the device became polarized and formed mature tight junction

99 es their integration in multi-spin nanoscale devices, because the field cannot be localized or screen

100 s the potential to yield commercially viable devices, but it also sharpens our understanding of the d

101 for electronic, optoelectronic, and quantum devices, but technological implementation will be hamper

102 ffers a new platform to design novel quantum devices by marrying the advantages of topological materi

103 ation of hybrid organic-inorganic perovskite devices by moisture.

104 boost the energy efficiency of semiconductor devices by using the self-adaptive evaporative cooling o

105 Our device can be readily extended to other EF frequency and

106 based high electron mobility transistor, the device can control significant output power modulation (

107 This device can emulate important characteristics of PPN such

108 o fields into a single layer, where a single device can record optical data, convert it into a conduc

109 al characteristics, the performance of these devices can be tuned.

110 nd SRNs in hardware using emerging nanoscale devices can greatly improve the efficiency of bionic med

111 printing was used to develop an open access device capable of simultaneous electrical and mechanical

112 lteplase treatment and declared endovascular device choice.

113 rphology was compared against a volume clamp device (CNSystems CNAP 500) (n = 3) resulting in similar

114 necessary incentives for pharmaceutical and device companies to generate comparative data on drugs a

115 Other major device complications including infection and lead fractu

116 s in device programming, while occurrence of device complications, such as lead fractures/infection,

117 arization and are promising energy-efficient device components for digital information storage.

118 will lead to the production of an effective device, comprehensibly mitigating infection transmission

119 chemical properties as well as assessing the device configuration, electrochemical reaction, and perf

120 In those works, a planar FAIMS device coupled with a Thermo Elite mass spectrometer was

121 Central venous access devices (CVAD) are used to deliver intravenous therapy t

122 g, and microscopy can be related directly to device degradation and are attributed to the significant

123 ) is one of the main reasons for accelerated device degradation.

124 All biometry devices delivered highly reproducible measurements, and

125 The device design is optimized to make all fluid particles i

126 ing, electromyography-driven simulation, and device design.

127 Unfortunately, the linear range of this device did not match the relevant clinical range for glu

128 A nanofluidic device directly monitors the protein size and quantity i

129 ic pixels by combining a digital micromirror device (DMD), an air-free reaction chamber, and microflu

130 r controlling optical properties of photonic devices dynamically.

131 ar cells (OSCs) is a key approach to improve device efficiencies.

132 This device enabled independent access to the apical and baso

133 eaming electrolyte flow during charging, the device enables dense Li plating and avoids porosity and

134 a surface acoustic wave nebulization (SAWN) device enhanced sampling performance for both polar and

135 fety; PV isolation success is improving with device enhancements.

136 The larger devices exhibited the maximum IQE at a lower current den

137 This device exhibits a high proton conductivity, fast respons

138 The devices exploit a bioresorbable dynamic covalent polymer

139 ructures will potentially lead to accessible device fabrication for 'on-demand' applications.

140 g three different FDA-approved human inhaler devices followed by interaction parameter analyses.

141 erably facilitate the built-up of a portable device for determination of analytes at the point-of-nee

142 apid, and non-invasive healthcare monitoring device for immense applications in health personalizatio

143 A microfluidic device for simultaneous analysis of total flavonoids and

144 el-based separation-free point-of-care (POC) device for whole blood glucose colorimetric detection.

145 es, activity monitors, and handheld computer devices for 6 months in hospital and at home.

146 ise in designing multifunctional intelligent devices for a wide range of applications.

147 rees as sustainable functional materials and devices for critical applications is thus provided.

148 fabrication techniques for realizing viable devices for long-term peripheral interfacing.

149 further exploited in design of microfluidic devices for rare cells immunocapture.

150 cate the suitability of our integrated paper devices for timely identification of bacterial infection

151 lly used by pathologists, as a complementary device, for real-time diagnosis of suspicious margins of

152 By simultaneously optimizing device geometry, driving parameters, and material charac

153 of the Lamb wave traveling on the polymeric device has been obtained in comparison with SAWs traveli

154 the nonreciprocal sensitivity of the antenna devices has been achieved by applying electromagnetic wa

155 of triaxial acceleration by animal-attached devices has been proposed as a way forward for this, wit

156 p apnea; however, studies using the WatchPAT device have thus far excluded patients with arrhythmias

157 Droplet-based microfluidic devices have become widely used to perform single-cell R

158 heart transplant and left ventricular assist devices have been the mainstay of treatment.

159 es of the potential opportunities that these devices have for the advanced sensing of pharmaceutical

160 The 2 MIGS devices have similar safety profiles.

161 by unconventional, hand-operated centrifuge devices (high volume) or plasma separation membranes (PS

162 valve IE and cardiac implantable electronic devices IE.

163 ilding energy simulation shows our dual-mode device, if widely deployed in the United States, can sav

164 y, with application of the negative pressure device immediately after repair of the surgical incision

165 ter (median=82 days) left ventricular assist device implantation (stage D; primary analysis) and ARNI

166 associated with increased ventricular assist device implantation in blacks.

167 te outcome of all-cause mortality, LV assist device implantation, or heart transplantation was assess

168 ratio with control patients who received new devices implanted in Canada.

169 e HOME study, the utility of the ForeseeHome device in the current analysis of clinical practice appl

170 tailored prescription of affordable digital devices in addition to usual care for people with mobili

171 treatment, especially as portable inhalation devices in high-risk, resource-poor settings.

172 at the nanoscale is crucially important for devices in nano-electronics, nanophotonics and quantum i

173 rogramming of cardiac implantable electronic devices in patients with HFrEF on the basis of individua

174 Patients who received reused devices in this program were matched in a 1:3 ratio with

175 f most electronic devices sampled, including devices in which the use of phthalates was not expected.

176 The implanted devices included 38 dual-chamber pacemakers, 17 cardiac

177 Cardiac devices included pacemakers (46%), ICDs (30%), cardiac r

178 or the detection of myocardial infiltration, device infection, and cardiovascular inflammation are su

179 Through integrated efforts on both sensor device innovation and machine learning data analytics, t

180 In addition, the single sensor device integrated in the cross-reactive sensor matrix ex

181 In devices integrated on flexible polymers, enhanced room-t

182 We report a novel lab-on-a-chip device integrating a multigate electrolyte gated organic

183 For example, the facile device integration was used to attach the well-known ant

184 owledge gap between materials innovation and device integration.

185 All participants had device interrogations performed before and after each MR

186 and the bottom gate was used for biasing the device into the optimum characteristic region for high s

187 Furthermore, the device is compatible with various neurophysiological tec

188 When the device is connected to an inline pressure sensor a clott

189 The device is first fabricated on a planar Si wafer at the m

190 The coupled SPS in the devices is driven by the external magnetic field to perf

191 structures and carbon-derived energy storage devices is presented with particular emphasis on correla

192 g of film formation, key to optimizing these devices, is lacking.

193 vailable soy allergen detection lateral flow devices (LFDs).

194 wing continuous flow Left Ventricular Assist Device (LVAD) implant vary: some centers continue CRT wh

195 and mortality after left ventricular assist device (LVAD) implantation.

196 nders [R]) following left ventricular assist device (LVAD)-induced mechanical unloading.

197 avascular microaxial left ventricular assist devices (LVADs) provide greater hemodynamic support as c

198 ts were substantially more likely to receive devices made by the manufacturer that provided the large

199 ree to commercialized tools, with integrated device mass manufacturing cost still not at a competitiv

200 The devices native setup shows limited ability to perform a

201 vided with a high-volume membrane filtration device (NuFiltration).

202 A multispectral retinal imaging device obtained precise measurements of retinal reflecta

203 produced by a number of everyday electronic devices on the measurements made by an eyemate(R)-IO sen

204 Most devices only work well for a narrow range of particle si

205 side-reactions with molecular oxygen during device operation.

206 en, fibrin-based ECM within our microfluidic device optimally (1) enhances the sprouting and migratio

207 al soft materials for future use in flexible devices or soft-robotic machines.

208 ation, which was unrelated to the procedure, device, or stimulation.

209 , virtual reality and information processing devices, or medical imaging.

210 Among these devices, pencil-drawn graphite patterns (or combined wit

211 While bulk defects are detrimental for the device performance by mainly limiting the open circuit v

212 The device performance was characterized using four prostate

213 heir localized areas, rarely prove fatal for device performance, and are largely not responsible for

214 eter-sized single crystals and achieved high device performance.

215 lternate phases and, therefore, more optimal device performance.

216 ation have narrower bandgap and thus enhance device photocurrent.

217 Our results support the exploration of device platforms already used in energy research to iden

218 mainly limited by the imprecision related to device programming and temporal drift of conductance val

219 ow-up, likely reflecting standard changes in device programming, while occurrence of device complicat

220 A set of near-infrared devices providing directional photodetection peaked at d

221 European Medicines Agency, European medical device regulatory agencies, US Food and Drug Administrat

222 The primary safety end points were device related death or adverse events, and major bleedi

223 ntermediate-risk PE, there were no deaths or device-related adverse events and a significant reductio

224 few surgical complications and no unexpected device-related AEs.

225 erior to the transvenous ICD with respect to device-related complications and inappropriate shocks.

226 No major device-related or procedural-related safety events occur

227 We demonstrate soft devices relevant to a broad range of disciplines: models

228 However, current ovonic threshold switching devices rely heavily on intricate control of material st

229 pectancy and long-term costs associated with device replacement, follow-up, and healthcare utilizatio

230 With one device replacing the equivalent of 10 glass slides of em

231 Organ-on-chip (OOC) devices are miniaturized devices replacing animal models in drug discovery and to

232 A variety of wearable technology devices report heart rate.

233 ry low RSD of 2.6%, revealing good device-to-device reproducibility.

234 The device's ability to chronically record local field poten

235 quencies in surface wipes of most electronic devices sampled, including devices in which the use of p

236 abling measurement in triplicate, and of the device selectivity through the presence of an internal r

237 Future studies with this device should contribute to the ongoing debate about the

238 ti-fibrotics and Baerveldt glaucoma drainage devices showed the greatest success in obtaining IOP con

239 ormance, and are largely not responsible for device shunting.

240 le-resonance TADF emitter, the corresponding device simultaneously realizes a maximum external quantu

241 Basic material properties and device structures of TFTs in commercial displays are exp

242 hrough confined spaces within a microfluidic device, subcellular photoactivation of Rac1, diffusion o

243 Valve Academic Research Consortium-2 device success was similar between Sapien 3 and Evolut R

244 ervention group who swallowed the Cytosponge device successfully, 221 (13%) underwent endoscopy after

245 , which are comparable to several commercial devices such as Pb-acid and Ni/MH batteries.

246 resistive gas sensor fully integrated into a device that communicates wirelessly with a smartphone.

247 we introduce, validate, and apply a magnetic device that generates a uniform magnetic field gradient

248 l, spray-capillary is a simple microsampling device that holds great potential for high-throughput qu

249 of marcAST is a ready-to-use microwell array device that is preassembled with custom titers of variou

250 Similarly, a phase battery is a quantum device that provides a persistent phase bias to the wave

251 his study reports an integrated microfluidic device that was capable of executing rapid antimicrobial

252 rather to a group of distinct procedures and devices that aim to decrease intraocular pressure.

253 for more capable biocompatible triboelectric devices that can continuously monitor vital physiologica

254 The development of energy storage devices that can endure large and complex deformations i

255 Consumer wearable devices that continuously measure vital signs have been

256 ign and assembly of microfluidic paper-based devices that use Cas12a-sensitive hydrogels to convert D

257 , body-fixed sensors, or domestic-integrated devices) that quantify mobility in unsupervised, daily l

258 When we add sender devices, the resulting patterning circuit produces theor

259 xciting class of materials for bioelectronic devices, they are susceptible to electrochemical side-re

260 multaneously reach 87% given the calibration device threshold tolerance of +/-3%.

261 t and ion mobility in a trapped ion mobility device (timsTOF Pro) to devise a scan mode that samples

262 EMR+ procedure, allowing a second endoscopic device to be used through the AWC while using otherwise

263 nto a custom-designed stopped-flow injection device to collect visible absorption and fluorescence EE

264 Further, we applied this device to control the cell division process by micrograv

265 we demonstrate a portable and real-time POC device to detect SARS-CoV-2 from VTM samples using an ad

266 we evaluated the ability of a stabilization device to preserve canine fecal samples under various st

267 n to usual care, the intervention group used devices to target mobility and physical activity problem

268 lythiophene-based solid-state electrochromic devices to understand and validate the mechanism of bias

269 bited a very low RSD of 2.6%, revealing good device-to-device reproducibility.

270 rent data surplus stemming from all types of devices together with the relentless increase in compute

271 testing of a disposable, multiplexed sensing device (ToMMx), which is a portable, high-throughput and

272 partially recovered (left ventricular assist device treatment) adult human hearts.

273 The main risks in patients with DBS devices undergoing MRI are heating at the electrode tips

274 embrane oxygenation, or a combination of MCS device use), or medical therapy only.

275 hemical and cellular microgravity responsive device using an engineered genetic circuit in E.coli, wh

276 The device utilizes microfabricated planar electrodes projec

277 While the Argus II device was active, walking speed increased from baseline

278 The polycaprolactone (PCL) device was placed including inside the fistulous surface

279 The WatchPAT (WP) device was shown to be accurate for the diagnosis of sle

280 ing more than 60 minutes daily on electronic devices was associated significantly with both myopia an

281 ces, although a wide variety of products and devices was reported.

282 and hypercapnia, home BPAP, compared with no device, was associated with lower risk of mortality, all

283 t thickness on the reliability of electronic devices; we will illustrate that the thermal cycling var

284 measurements, and that cholangiocytes in the device were mechanosensitive (as demonstrated by changes

285 The devices were created with controllable hot and cold regi

286 Data collected from the commercial devices were extracted for later comparison against EEG

287 o raise the prospect of future biocompatible devices where peptide assemblies could complex with nati

288 e the capturing chambers of the microfluidic device, where the hydrodynamic force then induces precis

289 experimentally, we fabricated a microfluidic device with 10 distributed Coulter sensors designed to p

290 on mode in one single run using a single CBS device with analysis times as short as 1 min per sample

291 s, higher modified thrombus grade post first device with consequently higher use of glycoprotein IIb/

292 batteries are next generation energy storage devices with high energy density, but face challenges in

293 n of novel storage paradigms, materials, and devices with increasing data density.

294 may pave a new way to design new 3D graphene devices with preserved 2D electronic properties and nove

295 These devices with the optimal flow rate (1 mL/h) and channel

296 d obtaining nanoparticle-based materials and devices with unique optical properties at the macroscale

297 our node Bayesian network using our proposed device, with parameters taken from the experiment.

298 an be realized on an integrated microfluidic device within 6 h.

299 fficiency in photovoltaic and optoelectronic devices, yet fundamental understanding of film formation

300 ed against a commercially available arm cuff device yielding systolic and diastolic readings ((mean+/